Skip to main content
Selvita S.A. logo

Selvita S.A. — Investor Relations & Filings

Ticker · SLV ISIN · PLSLVCR00029 LEI · 25940057WQ9YP5MOQF28 WAR Professional, scientific and technical activities
Open in API
Filings indexed 1,179 across all filing types
Latest filing 2025-09-29 Regulatory Filings
Country PL Poland
Listing WAR SLV

About Selvita S.A.

https://selvita.com/

Selvita S.A. is a preclinical contract research organization (CRO) providing integrated services for the pharmaceutical and biotechnology sectors. The company offers comprehensive solutions across the drug discovery and development continuum, from target validation to preclinical candidate nomination. Core drug discovery capabilities include medicinal chemistry, pharmacology, DMPK, and protein sciences, supporting a wide range of modalities such as small molecules, antibodies, and protein degraders. For drug development, Selvita provides analytical support for small and large molecules, formulation, microbiology services, and manufacturing for clinical trials. The company operates under GMP and GLP quality standards, offering flexible engagement models that range from standalone studies to fully integrated programs.

Recent filings

Filing Released Lang Actions
Rekomendowanie projektu Selvita S.A. do dofinansowania w ramach programu FENG / Recommendation of Selvita S.A. project for co-funding under the FENG program - Content (PL)
Regulatory Filings Classification · 100% confidence The document is an announcement from Selvita S.A. regarding the selection of their project for funding under the 'Fundusze Europejskie dla Nowoczesnej Gospodarki' program. It details the project scope, duration, and the specific financial grant amounts awarded. Since this is a regulatory announcement regarding corporate financing/funding activities and does not fit into specific categories like M&A or share issues, it is best classified as a general regulatory filing.
2025-09-29 Polish
Otrzymanie istotnego zlecenia / Receipt of a significant purchase order - Content (EN)
Regulatory Filings Classification · 100% confidence The document is a formal announcement by Selvita S.A. regarding the receipt of a significant purchase order from a client. It details the nature of the services, the contract duration, and the financial value of the order. Since this is a regulatory disclosure of a material business event that does not fit into specific categories like M&A, dividends, or share transactions, it falls under the general regulatory filing category.
2025-09-23 English
Otrzymanie istotnego zlecenia / Receipt of a significant purchase order - Content (PL)
Regulatory Filings Classification · 100% confidence The document is a formal announcement from Selvita S.A. regarding a significant contract order from a European biopharmaceutical client. It details the nature of the services, the duration of the contract, and the financial value of the order. Since this is a regulatory disclosure of a material business event (a significant contract) that does not fit into specific categories like M&A, dividends, or director dealings, it falls under the general regulatory filing category.
2025-09-23 Polish
Rekomendowanie projektu Selvita S.A. do dofinansowania w ramach programu FENG / Recommendation of Selvita S.A. project for co-funding under the FENG program - Content (EN)
Regulatory Filings Classification · 100% confidence The document is an official announcement from Selvita S.A. regarding the selection of their project for government co-funding under the FENG program. It details the nature of the project, the financial breakdown of the co-funding, and the strategic impact on the company's infrastructure and research capabilities. As this is a specific corporate announcement regarding financing and project development that does not fit into standard financial reporting categories like 10-K or IR, and is not a mere report publication notice, it is best classified as a Regulatory Filing (RNS) under the provided schema.
2025-09-19 English
Rekomendowanie projektu Selvita S.A. do dofinansowania w ramach programu FENG / Recommendation of Selvita S.A. project for co-funding under the FENG program - Content (PL)
Regulatory Filings Classification · 100% confidence The document is a formal announcement by Selvita S.A. regarding the selection of their project for co-funding under the FENG program. It details the nature of the project, the financial breakdown of the grant, and the strategic implications for the company's infrastructure and research capabilities. As this is a regulatory announcement regarding a specific corporate development (funding/financing) that does not fit into the other specific categories like 10-K or Earnings Release, it is classified as a Regulatory Filing (RNS).
2025-09-19 Polish
Independent registered auditor's report on the review of the interim condensed consolidated financial statements
Audit Report / Information Classification · 100% confidence The document is an 'Independent Auditor's Review Report' on interim condensed consolidated financial statements. It explicitly states it is a review report performed by an audit firm (BDO) regarding the financial statements of Selvita S.A. for the period ending 30 June 2025. According to the filing definitions, standalone audit reports and results of internal reviews (excluding full annual reports) fall under the 'Audit Report / Information' (AR) category. H1 2025
2025-09-18 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.